Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data-Reference-Cited by-同舟云学术

Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data

Published:2022-03-31 Issue:3 Volume:22 Page:198-209
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Rivers Zachary T.^ORCID,Parsons Helen M.,Jacobson Pamala A.,Kuntz Karen M.,Farley Joel F.,Stenehjem David J.

Funder

U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/s41397-022-00276-6.pdf

Reference53 articles.

1. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA: a cancer J clinicians. 2020;70:145–64.

2. National Comprehensive Cancer Network. Rectal Cancer (2021.1) 2021 [Available from: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.

3. National Comprehensive Cancer Network. Colon Cancer (Version 2021.2) 2021 [Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.

4. Genentech. Xeloda [package insert]. Package Insert. South San Francisco, CA; 2020.

5. Upjohn Company. Camptosar [package insert]. Package Insert. New York, New York.; 2020.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the pharmacy students' knowledge of genetic counseling with genetic variants that are associated with inherited disease;Currents in Pharmacy Teaching and Learning;2023-08